We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Tolero Pharmaceuticals

News List

Tolero Pharmaceuticals Announces Clinical Research Collaboration with AbbVie for Acute Myeloid Leukemia Trial pharmafocusasia
November 27, 2018
Tolero Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on developing treatments for hematologic and oncologic diseases...
Tolero Pharmaceuticals collaborates with AbbVie for AML trial biospectrumasia
August 21, 2018
Under the terms of the agreement, Tolero and AbbVie will equally share all development expenses. Tolero will retain full commercial rights for alvocidib and AbbVie will retain full commercial rights for venetoclax.
Tolero Pharmaceuticals, AbbVie Announces Clinical Research Collaboration americanpharmaceuticalreview
August 20, 2018
Tolero Pharmaceuticals has entered into a clinical research collaboration with AbbVie exploring the potential of combination therapy with AbbVie's venetoclax and Tolero's investigational agent, alvocidib, for the treatment of relapsed/refractory acute mye